GEN Exclusives

More »

GEN News Highlights

More »
Jan 31, 2007

Cellzome and J&JPRD Extend Alzheimer’s Partnership

  • Cellzome, Ortho-McNeil Pharmaceutical, and its affiliate Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) extended their joint research program aimed at identifying new medicines for the treatment of Alzheimer’s disease for one year.

    First announced in March 2005, the collaboration provides J&JPRD with Cellzome’s Amyloid Precursor Protein processing pathway map containing new drug targets, its chemical proteomics technology, and novel small molecules targeted at Gamma Secretase.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?